# OnCo record pgdx-elio-tissue-complete-cdx (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/pgdx-elio-tissue-complete-cdx/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "pgdx-elio-tissue-complete-cdx" ;
  schema:name "PGDx elio tissue complete CDx"@en ;
  schema:description "A tumour sequencing test approved in July 2026 as a companion diagnostic that finds BRAF V600E or V600K in melanoma, the mutations BRAF-targeted drugs act on."@en ;
  schema:url <https://onco.cc/drugs/pgdx-elio-tissue-complete-cdx/> ;
  schema:dateModified "2026-11-19"^^xsd:date ;
  schema:citation <https://api.fda.gov/device/pma.json?search=pma_number:P250036+AND+supplement_number:%22%22>, <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P250036>, <https://www.fda.gov/medical-devices/in-vitro-diagnostics/list-fda-authorized-companion-diagnostic-devices-in-vitro-and-imaging-tools> ;
  onco:status "approved" ;
  onco:tag "test" ;
  onco:modality "Tissue NGS companion diagnostic test (BRAF V600E and V600K in melanoma)" ;
  schema:alternateName "PGDx elio tissue complete CDx" ;
  onco:approval "US 2026: BRAF V600E and V600K in melanoma, for BRAF inhibitors and BRAF and MEK inhibitor combinations approved by the FDA for that indication (group labelling)" ;
  onco:related <https://onco.cc/drugs/cobas-4800-braf-v600/>, <https://onco.cc/drugs/thxid-braf/> ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/companion-diagnostic/> ;
  onco:targets <https://onco.cc/targets/braf/> ;
  onco:drugs <https://onco.cc/drugs/dabrafenib/>, <https://onco.cc/drugs/vemurafenib/>, <https://onco.cc/drugs/cobimetinib/>, <https://onco.cc/drugs/encorafenib/>, <https://onco.cc/drugs/binimetinib/>, <https://onco.cc/drugs/trametinib/> ;
  onco:terms <https://onco.cc/terms/ngs/>, <https://onco.cc/terms/companion-diagnostic-term/> .
